OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID‐19: Virology, biology and novel laboratory diagnosis
Malihe Mohamadian, Hossein Chiti, Alireza Shoghli, et al.
The Journal of Gene Medicine (2020) Vol. 23, Iss. 2
Open Access | Times Cited: 350

Showing 1-25 of 350 citing articles:

Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis
Raffaella Di Girolamo, Asma Khalil, Sara Alameddine, et al.
American Journal of Obstetrics & Gynecology MFM (2021) Vol. 3, Iss. 6, pp. 100468-100468
Open Access | Times Cited: 147

SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines
Suresh Thakur, Shalitha Sasi, Sindhu Gopinathan Pillai, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 141

Determinants of parental hesitancy to vaccinate their children against COVID-19 in China
Meixian Zhang, Xiaoqing Lin, Yan Chen, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1339-1349
Closed Access | Times Cited: 64

Basophils and Mast Cells in COVID-19 Pathogenesis
Giuseppe Murdaca, Mario Di Gioacchino, Mónica Greco, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2754-2754
Open Access | Times Cited: 64

Phytocompounds as potential inhibitors of SARS-CoV-2 Mpro and PLpro through computational studies
Mithun Rudrapal, İsmail Çeli̇k, Sampath Chinnam, et al.
Saudi Journal of Biological Sciences (2022) Vol. 29, Iss. 5, pp. 3456-3465
Open Access | Times Cited: 46

An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)
Reza Elahi, Parsa Karami, Amir Hossein Heidary, et al.
International Immunopharmacology (2022) Vol. 105, pp. 108536-108536
Open Access | Times Cited: 45

Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19
Wei Xia, Yafeng Tan, Shengmei Hu, et al.
Clinical and Applied Thrombosis/Hemostasis (2022) Vol. 28
Open Access | Times Cited: 45

OMICRON: Virology, immunopathogenesis, and laboratory diagnosis
Mahsa Bazargan, Reza Elahi, Abdolreza Esmaeilzadeh
The Journal of Gene Medicine (2022) Vol. 24, Iss. 7
Open Access | Times Cited: 42

Unwinding circular RNA’s role in inflammatory pulmonary diseases
Asif Ahmad Bhat, Gaurav Gupta, Ahsas Goyal, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2567-2588
Closed Access | Times Cited: 40

Nanopore sequencing technology and its applications
Peijie Zheng, Chuntao Zhou, Yuemin Ding, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 34

Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas
Zaid Khreefa, Mallory T. Barbier, Ali Rıza Köksal, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 262-262
Open Access | Times Cited: 28

Human Endogenous Retrovirus (HERV) Transcriptome Is Dynamically Modulated during SARS-CoV-2 Infection and Allows Discrimination of COVID-19 Clinical Stages
Nicole Grandi, Maria Chiara Erbì, Sante Scognamiglio, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 23

EG.5 (Eris) and BA.2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19
Abdolreza Esmaeilzadeh, Fereshteh Ebrahimi, Armin Jahani Maleki, et al.
Infection (2024) Vol. 52, Iss. 2, pp. 337-343
Closed Access | Times Cited: 10

Dysphonia and COVID-19: A Review
Regina Helena Garcia Martins, Elsa Azevedo, Janis A. Müller, et al.
Journal of Voice (2025)
Closed Access | Times Cited: 1

Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge
Hongwei Li, Xue Li, Qian Wu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 38

Sustainable materials and COVID-19 detection biosensor: A brief review
Sora Yasri, Viroj Wiwanitkit
Sensors International (2022) Vol. 3, pp. 100171-100171
Open Access | Times Cited: 31

Computational Investigations for Identification of Bioactive Molecules from Baccaurea ramiflora and Bergenia ciliata as Inhibitors of SARS-CoV-2 Mpro
James H. Zothantluanga, Mohnad Abdalla, Mithun Rudrapal, et al.
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 3, pp. 2459-2487
Closed Access | Times Cited: 29

Severe Acute Respiratory Syndrome Coronavirus‐2
Patricia Slev
(2024), pp. 572-582
Closed Access | Times Cited: 8

First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report
Victoria T. Mücke, Viola Knop, Marcus M. Mücke, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 40

Multiomics integration-based molecular characterizations of COVID-19
Chuanxing Li, Jing Gao, Zicheng Zhang, et al.
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 40

Intriguing new faces of Covid-19: persisting clinical symptoms and cardiac effects in children
Nurdan Erol, Abdullah Alpınar, Çiğdem Erol, et al.
Cardiology in the Young (2021) Vol. 32, Iss. 7, pp. 1085-1091
Open Access | Times Cited: 39

Page 1 - Next Page

Scroll to top